Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorANUARDO, Pedro
dc.contributor.authorVERDIER, Monica
dc.contributor.authorGORMEZANO, Natali W. S.
dc.contributor.authorFERREIRA, Gabriela R. V.
dc.contributor.authorLEAL, Gabriela N.
dc.contributor.authorLIANZA, Alessandro
dc.contributor.authorFERREIRA, Juliana C. O. A.
dc.contributor.authorPEREIRA, Rosa M. R.
dc.contributor.authorAIKAWA, Nadia E.
dc.contributor.authorTERRERI, Maria Teresa
dc.contributor.authorMAGALHES, Claudia S.
dc.contributor.authorAPPENZELLER, Simone
dc.contributor.authorSANTOS, Maria Carolina dos
dc.contributor.authorSACHETTI, Silvana B.
dc.contributor.authorLEN, Claudio A.
dc.contributor.authorPILLEGGI, Gecilmara S.
dc.contributor.authorLOTUFO, Simone
dc.contributor.authorBONFA, Eloisa
dc.contributor.authorSILVA, Clovis A.
dc.date.accessioned2017-06-09T15:18:21Z
dc.date.available2017-06-09T15:18:21Z
dc.date.issued2017
dc.description.abstractThe aim of this study was to evaluate pulmonary hypertension (PH) in 852 childhood-onset systemic lupus erythematosus (cSLE) patients. This was a large multicenter study conducted in 10 Pediatric Rheumatology Services of So Paulo state, Brazil. PH was defined as systolic pulmonary artery pressure > 35 mmHg and/or measurement of the mean pulmonary artery pressure > 25 mmHg and/or diastolic pressure > 15 mmHg by transthoracic echocardiogram. Demographic data, clinical manifestations, disease activity score (SLEDAI-2K), disease damage score (SLICC/ACR-DI) and treatments were also evaluated. Statistical analysis was performed using Bonferroni correction (p < 0.002). PH was observed in 17/852 (2%) cSLE patients. Effort dyspnea occurred in 3/17, chest pain in 1/17 and right ventricle dysfunction in 3/17 cSLE patients. None had pulmonary thromboembolism or antiphospholipid syndrome. Further comparison between 17 cSLE with PH and 85 cSLE control patients without PH with similar disease duration [15 (0-151) vs. 15 (0-153) months, p = 0.448], evaluated at the last visit, revealed higher frequencies of fever (47 vs. 9%, p < 0.001), reticuloendothelial manifestations (41 vs. 7%, p < 0.001) and serositis (35 vs. 5%, p = 0.001) in the former group. Frequencies of renal and neuropsychiatric involvements and antiphospholipid syndrome, as well as the median of SLEDAI-2K and SLICC/ACR-DI scores, were comparable in both groups (p > 0.002). Normal transthoracic echocardiography was evidenced in 9/17 (53%), with median cSLE duration of 17.5 months (1-40) after PH standard treatment. PH was a rare manifestation of cSLE occurring in the first two years of disease. The majority of patients were asymptomatic with mild lupus manifestations. The underlying mechanism seemed not to be related to pulmonary thromboembolism and/or antiphospholipid syndrome.
dc.description.indexMEDLINE
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301805/2013-0, 303752/2015-7, 301479/2015-1, 305068/2014-8, 303422/2015-7]
dc.description.sponsorshipFederico Foundation
dc.description.sponsorshipNucleo de Apoio a Pesquisa ""Saude da Crianc, a e do Adolescente'' da USP (NAP-CriAd)
dc.identifier.citationPEDIATRIC CARDIOLOGY, v.38, n.2, p.234-239, 2017
dc.identifier.doi10.1007/s00246-016-1504-6
dc.identifier.eissn1432-1971
dc.identifier.issn0172-0643
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/19950
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofPediatric Cardiology
dc.rightsrestrictedAccess
dc.rights.holderCopyright SPRINGER
dc.subjectPulmonary hypertension
dc.subjectChildhood systemic lupus erythematosus
dc.subjectLung
dc.subjectMulticenter cohort
dc.subject.otherarterial-hypertension
dc.subject.otherinvolvement
dc.subject.otherprevalence
dc.subject.otherdiagnosis
dc.subject.othercriteria
dc.subject.otherregistry
dc.subject.otherindex
dc.subject.wosCardiac & Cardiovascular Systems
dc.subject.wosPediatrics
dc.titleSubclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalFERREIRA, Gabriela R. V.:Univ Sao Paulo, Fac Med, Childrens Inst, Pediat Rheumatol Unit, Sao Paulo, Brazil
hcfmusp.author.externalTERRERI, Maria Teresa:Univ Fed Sao Paulo, Pediat Rheumatol Unit, Sao Paulo, Brazil
hcfmusp.author.externalMAGALHES, Claudia S.:Sao Paulo State Univ UNESP, Fac Med Botucatu, Sao Paulo, Brazil
hcfmusp.author.externalAPPENZELLER, Simone:Univ Estadual Campinas, Campinas, SP, Brazil
hcfmusp.author.externalSANTOS, Maria Carolina dos:Irmandade Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil
hcfmusp.author.externalSACHETTI, Silvana B.:Irmandade Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil
hcfmusp.author.externalLEN, Claudio A.:Univ Fed Sao Paulo, Pediat Rheumatol Unit, Sao Paulo, Brazil
hcfmusp.author.externalPILLEGGI, Gecilmara S.:Univ Sao Paulo, Ribeirao Preto Med Sch, Sao Paulo, Brazil
hcfmusp.author.externalLOTUFO, Simone:Hosp Menino Jesus, Sao Paulo, Brazil
hcfmusp.citation.scopus13
hcfmusp.contributor.author-fmusphcPEDRO ADDE ANUARDO
hcfmusp.contributor.author-fmusphcMONICA VERDIER
hcfmusp.contributor.author-fmusphcNATALI WENIGER SPELLING GORMEZANO
hcfmusp.contributor.author-fmusphcGABRIELA NUNES LEAL
hcfmusp.contributor.author-fmusphcALESSANDRO CAVALCANTI LIANZA
hcfmusp.contributor.author-fmusphcJULIANA CAIRES DE OLIVEIRA ACHILI FERREIRA
hcfmusp.contributor.author-fmusphcROSA MARIA RODRIGUES PEREIRA
hcfmusp.contributor.author-fmusphcNADIA EMI AIKAWA
hcfmusp.contributor.author-fmusphcELOISA SILVA DUTRA DE OLIVEIRA BONFA
hcfmusp.contributor.author-fmusphcCLOVIS ARTUR ALMEIDA DA SILVA
hcfmusp.description.beginpage234
hcfmusp.description.endpage239
hcfmusp.description.issue2
hcfmusp.description.volume38
hcfmusp.origemWOS
hcfmusp.origem.pubmed27826712
hcfmusp.origem.scopus2-s2.0-84994417490
hcfmusp.origem.wosWOS:000395096700004
hcfmusp.publisher.cityNEW YORK
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAkdogan A, 2013, JCR-J CLIN RHEUMATOL, V19, P421, DOI 10.1097/RHU.0000000000000037
hcfmusp.relation.referenceThe American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes, 1999, ARTHRITIS RHEUM, V42, P599
hcfmusp.relation.referenceAvcin T, 2009, LUPUS, V18, P894, DOI 10.1177/0961203309106917
hcfmusp.relation.referenceBadesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011
hcfmusp.relation.referenceBeresford M. W., 2005, Lupus, V14, P152, DOI 10.1191/0961203305lu2073oa
hcfmusp.relation.referenceBRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
hcfmusp.relation.referenceCiftci E, 2004, RHEUMATOLOGY, V43, P587, DOI 10.1093/rheumatology/keh120
hcfmusp.relation.referenceDELGADO EA, 1990, SEMIN ARTHRITIS RHEU, V19, P285, DOI 10.1016/0049-0172(90)90051-G
hcfmusp.relation.referenceGladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303
hcfmusp.relation.referenceGladman DD, 2002, J RHEUMATOL, V29, P288
hcfmusp.relation.referenceHassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006
hcfmusp.relation.referenceHochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
hcfmusp.relation.referenceHuggins JL, 2016, LUPUS, V25, P857, DOI 10.1177/0961203316644339
hcfmusp.relation.referenceJohnson SR, 2004, LUPUS, V13, P506, DOI 10.1191/0961203303lu1051oa
hcfmusp.relation.referenceKamel Shereen R, 2011, Clin Med Insights Arthritis Musculoskelet Disord, V4, P77, DOI 10.4137/CMAMD.S7667
hcfmusp.relation.referenceKhetarpal R, 1997, SCAND J RHEUMATOL, V26, P325
hcfmusp.relation.referenceKoestenberger M, 2016, HEART, V102, P14, DOI 10.1136/heartjnl-2014-307200
hcfmusp.relation.referenceKommireddy S, 2015, RHEUMATOLOGY, V54, P1673, DOI 10.1093/rheumatology/kev097
hcfmusp.relation.referenceLeal GN, 2015, LUPUS, V24, P613, DOI 10.1177/0961203314563135
hcfmusp.relation.referenceLi M, 2014, LUPUS, V23, P1085, DOI 10.1177/0961203314527366
hcfmusp.relation.referencePerez-Penate GM, 2016, J RHEUMATOL, V43, P323, DOI 10.3899/jrheum.150451
hcfmusp.relation.referenceMin HK, 2015, KOREAN J INTERN MED, V30, P232, DOI 10.3904/kjim.2015.30.2.232
hcfmusp.relation.referenceNational High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, 2004, PEDIATRICS, V114, P555, DOI 10.1542/PEDS.114.2.S2.555
hcfmusp.relation.referenceNicholson GT, 2013, PEDIATR CARDIOL, V34, P1966, DOI 10.1007/s00246-012-0510-6
hcfmusp.relation.referenceSilva CA, 2016, EXPERT REV CLIN IMMU, V12, P301, DOI 10.1586/1744666X.2016.1123621
hcfmusp.relation.referenceTakatsuki S, 2011, PEDIATR CARDIOL, V32, P828, DOI 10.1007/s00246-011-9950-7
hcfmusp.relation.referenceVeiga CS, 2016, LUPUS, V25, P645, DOI 10.1177/0961203316629554
hcfmusp.relation.referenceWare Dhananjay, 2015, J Assoc Physicians India, V63, P17
hcfmusp.scopus.lastupdate2024-04-12
relation.isAuthorOfPublication2ce93832-d44c-4fe3-9f74-336d66b848a6
relation.isAuthorOfPublication54501d29-5731-4f29-9192-9201120fc3de
relation.isAuthorOfPublicationec7c4c42-6b7d-4c82-8764-c5f692d37cec
relation.isAuthorOfPublicationa3b5e39d-525f-4648-87bb-229222d307ba
relation.isAuthorOfPublication83e2a92e-5fa9-42e5-ab91-dd930c9d3e72
relation.isAuthorOfPublicationdc754fcb-1524-41cf-bffd-b1d6719e37bb
relation.isAuthorOfPublicationa7d269ab-50f5-415f-a84f-b03f05f2093c
relation.isAuthorOfPublicationd269a535-0477-491e-84b5-73ed38da4033
relation.isAuthorOfPublication708e64de-56af-4523-b920-b237f71535b2
relation.isAuthorOfPublication6c3c5459-9dbb-4a5c-98b1-d7b76943b87d
relation.isAuthorOfPublication.latestForDiscovery2ce93832-d44c-4fe3-9f74-336d66b848a6
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_ANUARDO_Subclinical_Pulmonary_Hypertension_in_Childhood_Systemic_Lupus_Erythematosus_2017.PDF
Tamanho:
349.7 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion(English)